[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4014/jmb.2101.01029

Deoxypodophyllotoxin Inhibits Cell Growth and Induces Apoptosis by Blocking EGFR and MET in Gefitinib-Resistant Non-Small Cell Lung Cancer

Kim, Han Sol (Department of Pharmacy, College of Pharmacy, Mokpo National University)
Oh, Ha-Na (Department of Pharmacy, College of Pharmacy, Mokpo National University)
Kwak, Ah-Won (Department of Pharmacy, College of Pharmacy, Mokpo National University)
Kim, Eunae (College of Pharmacy, Chosun University)
Lee, Mee-Hyun (College of Korean Medicine, Dongshin University)
Seo, Ji-Hye (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Cho, Seung-Sik (Department of Pharmacy, College of Pharmacy, Mokpo National University)
Yoon, Goo (Department of Pharmacy, College of Pharmacy, Mokpo National University)
Chae, Jung-Il (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Shim, Jung-Hyun (Department of Pharmacy, College of Pharmacy, Mokpo National University)

Publication Information

Journal of Microbiology and Biotechnology / v.31, no.4, 2021 , pp. 559-569 More about this Journal

Abstract

As one of the major types of lung cancer, non-small cell lung cancer (NSCLC) accounts for the majority of cancer-related deaths worldwide. Treatments for NSCLC includes surgery, chemotherapy, and targeted therapy. Among the targeted therapies, resistance to inhibitors of the epidermal growth factor receptor (EGFR) is common and remains a problem to be solved. MET (hepatocyte growth factor receptor) amplification is one of the major causes of EGFR-tyrosine kinase inhibitor (TKI) resistance. Therefore, there exists a need to find new and more efficacious therapies. Deoxypodophyllotoxin (DPT) extracted from Anthriscus sylvestris roots exhibits various pharmacological activities including anti-inflammation and anti-cancer effects. In this study we sought to determine the anti-cancer effects of DPT on HCC827GR cells, which are resistant to gefitinib (EGFR-TKI) due to regulation of EGFR and MET and their related signaling pathways. To identify the direct binding of DPT to EGFR and MET, we performed pull-down, ATP-binding, and kinase assays. DPT exhibited competitive binding with ATP against the network kinases EGFR and MET and reduced their activities. Also, DPT suppressed the expression of p-EGFR and p-MET as well as their downstreat proteins p-ErbB3, p-AKT, and p-ERK. The treatment of HCC827GR cells with DPT induced high ROS generation that led to endoplasmic-reticulum stress. Accordingly, loss of mitochondrial membrane potential and apoptosis by multi-caspase activation were observed. In conclusion, these results demonstrate the apoptotic effects of DPT on HCC827GR cells and signify the potential of DPT to serve as an adjuvant anti-cancer drug by simultaneously inhibiting EGFR and MET.

Keywords

Deoxypodophyllotoxin; gefitinib-resistant; lung cancer; apoptosis;

Citations & Related Records

Reference

1	Kawata T, Higashimori M, Itoh Y, Tomkinson H, Johnson MG, Tang W, et al. 2019. Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer. Cancer Chemother. Pharmacol. 83: 849-858. DOI
2	Khaw-On P, Pompimon W, Banjerdpongchai R. 2018. Apoptosis induction via ATM phosphorylation, cell cycle arrest, and ER stress by goniothalamin and chemodrugs combined effects on breast cancer-derived MDA-MB-231 cells. Biomed. Res. Int. 2018: 7049053.
3	Mao XM, Zhou P, Li SY, Zhang XY, Shen JX, Chen QX, et al. 2019. Diosgenin suppresses cholangiocarcinoma cells via inducing cell cycle arrest and mitochondria-mediated apoptosis. Onco. Targets Ther. 12: 9093-9104. DOI
4	Yang KM, Kim BM, Park JB. 2014. omega-Hydroxyundec-9-enoic acid induces apoptosis through ROS-mediated endoplasmic reticulum stress in non-small cell lung cancer cells. Biochem. Biophys. Res. Commun. 448: 267-273. DOI
5	Zheng YZ, Cao ZG, Hu X, Shao ZM. 2014. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. Breast Cancer Res. Treat. 145: 349-358. DOI
6	Tungjai M, Kantapan J, Bunmakat Y, Kothan S. 2015. Presented at the 2015 4th International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering (ICICI-BME).
7	Wang YR, Xu Y, Jiang ZZ, Guerram M, Wang B, Zhu X, et al. 2015. Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo. Molecules 20: 1661-1675. DOI
8	Wu M, Jiang Z, Duan H, Sun L, Zhang S, Chen M, et al. 2013. Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells. Biomed. Pharmacother. 67: 701-706. DOI
9	Guerram M, Jiang ZZ, Sun L, Zhu X, Zhang LY. 2015. Antineoplastic effects of deoxypodophyllotoxin, a potent cytotoxic agent of plant origin, on glioblastoma U-87 MG and SF126 cells. Pharmacol. Rep. 67: 245-252. DOI
10	Chen Y, Zhao K, Liu F, Li Y, Zhong Z, Hong S, et al. 2018. Predicting antitumor effect of deoxypodophyllotoxin in NCI-H460 rumorbearing mice on the basis of In Vitro pharmacodynamics and a physiologically based pharmacokinetic-pharmacodynamic model. Drug Metab. Dispos. 46: 897-907. DOI
11	Yang Y, Chen Y, Zhong ZY, Zhang J, Li F, Jia LL, et al. 2014. Validated LC-MS/MS assay for quantitative determination of deoxypodophyllotoxin in rat plasma and its application in pharmacokinetic study. J. Pharm. Biomed. Anal. 88: 410-415. DOI
12	Arulananda S, Do H, Musafer A, Mitchell P, Dobrovic A, John T. 2017. Combination osimertinib and gefitinib in C797S and T790M EGFR-Mutated non-small cell lung cancer. J. Thorac. Oncol. 12: 1728-1732. DOI
13	Lin F, Cao SB, Ma XS, Sun HX. 2017. Inhibition of casein kinase 2 blocks G2/M transition in early embryo mitosis but not in oocyte meiosis in mouse. J. Reprod. Dev. 63: 319-324. DOI
14	Shen X, Wu Z, Chen S, Chen Y, Xia J, Lv Y, et al. 2016. Induction of G2/M phase arrest and apoptosis by ZGDHU-1 in A549 and RERF-LC-MA lung cancer cells. Oncol. Lett. 12: 989-994. DOI
15	Kim E, Kim HJ, Cho S-S, Shim J-H, Yoon G. 2020. Isolation, semisynthesis, and molecular modeling of deoxypodophyllotoxin analogs for an anti-oral cancer agent. Bull. Korean Chem. Soc. 41: 472-475. DOI
16	Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. 2007. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316: 1039-1043. DOI
17	Oh HN, Lee MH, Kim E, Yoon G, Chae JI, Shim JH. 2019. Licochalcone B inhibits growth and induces apoptosis of human nonsmall-cell lung cancer cells by dual targeting of EGFR and MET. Phytomedicine 63: 153014. DOI
18	Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. 2019. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. 8: 1958-1975. DOI
19	Yi YW, You K, Bae EJ, Kwak SJ, Seong YS, Bae I. 2015. Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6. Int. J. Oncol. 47: 122-132. DOI
20	Tripathi SK, Rengasamy KRR, Biswal BK. 2020. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Arch. Pharm. Res. 43: 242-256. DOI
21	Wang W, Gao W, Zhang L, Zhang D, Zhao Z, Bao Y. 2019. Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells. Oncol. Rep. 41: 2453-2463.
22	Kitagawa C, Mori M, Ichiki M, Sukoh N, Kada A, Saito AM, et al. 2019. Gefitinib plus bevacizumab vs. gefitinib alone for EGFR mutant non-squamous non-small cell lung cancer. In Vivo 33: 477-482. DOI
23	Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M. 2019. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br. J. Cancer 121: 725-737. DOI
24	Ping W, Gao Y, Fan X, Li W, Deng Y, Fu X. 2018. MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7. Biochem. Biophys. Res. Commun. 495: 2482-2489. DOI
25	Shin SY, Yong Y, Kim CG, Lee YH, Lim Y. 2010. Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in HeLa cells. Cancer Lett. 287: 231-239. DOI
26	Park BR, Lee SA, Moon SM, Kim CS. 2018. Anthricininduced caspasedependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human non-small lung cancer cells. Oncol. Rep. 39: 2769-2776.
27	Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, et al. 2003. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res. 63: 831-837.
28	Li YC, He SM, He ZX, Li M, Yang Y, Pang JX, et al. 2014. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Lett. 344: 239-259. DOI
29	Lee MH, Cho Y, Kim DH, Woo HJ, Yang JY, Kwon HJ, et al. 2016. Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1. Am. J. Transl. Res. 8: 5246-5255.
30	Chang CH, Chen KY, Young-Xu Y, Kurth T, Orav EJ, Yang PC, et al. 2008. The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis. Lung Cancer 62: 242-252. DOI
31	Li Y, Yu H, Han F, Wang M, Luo Y, Guo X. 2018. Biochanin A Induces S phase arrest and apoptosis in lung cancer cells. Biomed. Res. Int. 2018: 3545376.
32	Zeng X, Li J, Peng L, Wang Y, Tan C, Chen G, et al. 2014. Economic outcomes of maintenance gefitinib for locally advanced/ metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis. PLoS One 9: e88881. DOI
33	Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, et al. 2017. Role of autophagy and apoptosis in non-small-cell lung cancer. Int. J. Mol. Sci. 18: 367. DOI
34	Wang C, Cui C. 2019. Inhibition of lung cancer proliferation by wogonin is associated with activation of apoptosis and generation of reactive oxygen species. Balkan Med. J. 37: 29-33.